These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 754679)

  • 1. [Immuno-stimulating effect of levamisole in the immunization of guinea pigs vaccinated against brucellosis].
    Sandoval LA; Giorgi W; Amaral LB; Zampolli E; Manzati MT
    Arq Inst Biol (Sao Paulo); 1978; 45(4):313-7. PubMed ID: 754679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
    Bolpe J; de Lapenta DF; García-Carrillo C
    Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against bovine brucellosis with a low dose of strain 19 administered by the conjunctival route. I.--Protection demonstrated in guinea pigs.
    Plommet M; Plommet AM
    Ann Rech Vet; 1975; 6(4):345-56. PubMed ID: 821381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levamisole synergizes experimental F4ac+ Escherichia coli oral vaccine in stimulating ileal Peyer's patch T cells in weaned pigs.
    Bozić F; Lacković G; Kovsca-Janjatović A; Smolec O; Valpotić I
    J Vet Pharmacol Ther; 2006 Jun; 29(3):199-204. PubMed ID: 16669864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of normal or immunized guinea pigs against a subcutaneous challenge of Brucella abortus.
    Pardon P; Marly J
    Ann Rech Vet; 1978; 9(3):419-25. PubMed ID: 107845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recent trial comparing two 45/20 adjuvant Brucella vaccines.
    McKeon FW
    Dev Biol Stand; 1976; 31():343-50. PubMed ID: 816690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venezuelan field trials of vaccines against brucellosis in swine.
    Lord VR; Cherwonogrodzky JW; Schurig GG; Lord RD; Marcano MJ; Meléndez GE
    Am J Vet Res; 1998 May; 59(5):546-51. PubMed ID: 9582954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient enhancement of the serum antibody response to Brucella abortus strain 19 in cattle treated with levamisole.
    Confer AW; Hall SM; Espe BH
    Am J Vet Res; 1985 Dec; 46(12):2440-3. PubMed ID: 3936383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of simultaneous inoculation of B. abortus strain 19 and foot-and-mouth disease vaccines on immunity against brucellosis in the guinea pig].
    García-Carrillo C
    Rev Asoc Argent Microbiol; 1978; 10(1):1-7. PubMed ID: 210482
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of antibrucellosis vaccines using guinea pigs].
    Le Garrec Y; Pilet C; Garrido-Calderon N
    Dev Biol Stand; 1976; 31():301-7. PubMed ID: 816686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence.
    Lord VR; Schurig GG; Cherwonogrodzky JW; Marcano MJ; Melendez GE
    Am J Vet Res; 1998 Aug; 59(8):1016-20. PubMed ID: 9706206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle.
    Olsen SC
    Vet Ther; 2000; 1(3):183-91. PubMed ID: 19757581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brucella abortus-specific immunoglobulin isotypes in serum and vaginal mucus from heifers vaccinated with Brucella abortus salt-extractable proteins and challenge exposed with virulent Brucella organisms.
    Hall SM; Confer AW
    Am J Vet Res; 1989 Dec; 50(12):1997-2003. PubMed ID: 2514615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia.
    Dénes B
    Acta Vet Hung; 1997; 45(1):33-43. PubMed ID: 9270127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51.
    Elzer PH; Enright FM; Colby L; Hagius SD; Walker JV; Fatemi MB; Kopec JD; Beal VC; Schurig GG
    Am J Vet Res; 1998 Dec; 59(12):1575-8. PubMed ID: 9858409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cell-mediated immune responses and bacterial clearance in 6-10 months old water buffalo (Bubalus bubalis) experimentally vaccinated with four dosages of commercial Brucella abortus strain RB51 vaccine.
    Diptee MD; Adesiyun AA; Asgarali Z; Campbell M; Fosgate GT
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):209-20. PubMed ID: 15963819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oxytetracycline administration on antibody response to Brucella abortus vaccination in calves.
    Smith RA; Thedford TR; Espe BH; Woodson PD; Burrows GE
    J Am Vet Med Assoc; 1983 Jul; 183(1):70-1. PubMed ID: 6409863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of strain RB51 vaccine in heifers against experimental brucellosis.
    Poester FP; Gonçalves VS; Paixão TA; Santos RL; Olsen SC; Schurig GG; Lage AP
    Vaccine; 2006 Jun; 24(25):5327-34. PubMed ID: 16713034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.